Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Mol Neurobiol. 2018 Oct 4;56(6):4151–4162. doi: 10.1007/s12035-018-1346-8

Fig 5: Alterations in levels of components of mTOR signaling pathway with loss of CDKL5 in striatal inhibitory (GAD65-positive) neurons.

Fig 5:

A. Western blots for components of the mTOR signaling pathway as indicated in cortical lysates from CDKL5 Fl/Y +/− Gad2-IRES-Cre tissue.

B. Levels of components of the mTOR signaling pathway relative to β-tubulin as indicated in cortical lysates from CDKL5 Fl/Y +/− Gad2-IRES-Cre tissue. (Data presented ± SEM, *=P<0.05, **=P<0.005, ***=P<0.0005, Student’s t-test with Welch correction. N=5 for each genotype. Age 4-20 weeks.)